Total Payments
$1,079
2024 Payments
$22.24
Companies
15
Transactions
50
Medicare Patients
1,829
Medicare Billing
$175,325
Payment Breakdown by Category
Food & Beverage$1,079 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,079 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $208.14 | 10 | $0 (2024) |
| ABBVIE INC. | $182.66 | 11 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $127.69 | 5 | $0 (2022) |
| Allergan Inc. | $113.54 | 1 | $0 (2017) |
| Lilly USA, LLC | $91.21 | 4 | $0 (2022) |
| Abbott Laboratories | $66.65 | 4 | $0 (2022) |
| GlaxoSmithKline, LLC. | $65.79 | 3 | $0 (2023) |
| ARBOR PHARMACEUTICALS, INC. | $58.65 | 3 | $0 (2021) |
| Amarin Pharma Inc. | $50.28 | 3 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $27.70 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.24 | 1 | Novo Nordisk Inc ($22.24) |
| 2023 | $52.51 | 2 | GlaxoSmithKline, LLC. ($32.22) |
| 2022 | $473.95 | 25 | ABBVIE INC. ($139.49) |
| 2021 | $397.24 | 20 | Novo Nordisk Inc ($68.17) |
| 2020 | $19.43 | 1 | Hologic, LLC ($19.43) |
| 2017 | $113.54 | 1 | Allergan Inc. ($113.54) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PAIN | ||||||
| 06/29/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2022 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 07/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: DIABETES | ||||||
| 07/11/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Diabetes | ||||||
| 06/30/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: PRIMARY CARE | ||||||
| 06/09/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: VACCINES | ||||||
| 06/03/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 05/31/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/19/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes Care | ||||||
| 05/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: DIABETES | ||||||
| 05/15/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Diabetes | ||||||
| 04/25/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes | ||||||
| 04/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 03/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 309 | 433 | $78,560 | $31,510 |
| 2022 | 7 | 300 | 441 | $78,980 | $34,038 |
| 2021 | 9 | 517 | 586 | $149,323 | $47,716 |
| 2020 | 16 | 703 | 977 | $209,163 | $62,061 |
Total Patients
1,829
Total Services
2,437
Medicare Billing
$175,325
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 195 | $48,750 | $17,258 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 54 | 54 | $14,850 | $7,334 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 41 | $8,200 | $2,373 | 28.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $2,250 | $2,158 | 95.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,360 | $1,105 | 81.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 52 | 52 | $2,340 | $1,024 | 43.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 27 | $810.00 | $257.04 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 202 | $50,500 | $19,491 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $13,475 | $6,966 | 51.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 41 | $8,200 | $3,162 | 38.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $2,250 | $2,056 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,360 | $1,087 | 79.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 43 | 43 | $1,935 | $874.38 | 45.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 27 | 42 | $1,260 | $401.87 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 217 | 277 | $81,310 | $23,491 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 87 | 87 | $35,820 | $12,633 | 35.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 83 | $17,260 | $5,346 | 31.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 13 | 14 | $8,920 | $3,438 | 38.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 19 | 19 | $1,425 | $1,240 | 87.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 28 | 28 | $1,260 | $581.56 | 46.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 42 | 45 | $1,560 | $436.95 | 28.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 22 | 22 | $905.00 | $407.46 | 45.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 11 | 11 | $863.00 | $142.82 | 16.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 226 | 440 | $128,480 | $32,122 | 25.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 76 | 91 | $7,300 | $5,238 | 71.8% |
About Dr. Mamta Singh, M.D
Dr. Mamta Singh, M.D is a Geriatric Medicine healthcare provider based in Willimantic, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1891031522.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mamta Singh, M.D has received a total of $1,079 in payments from pharmaceutical and medical device companies, with $22.24 received in 2024. These payments were reported across 50 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,079).
As a Medicare-enrolled provider, Singh has provided services to 1,829 Medicare beneficiaries, totaling 2,437 services with total Medicare billing of $175,325. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Willimantic, CT
- Active Since 12/28/2012
- Last Updated 04/02/2018
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1891031522
Products in Payments
- QULIPTA (Drug) $121.74
- NAMZARIC (Drug) $113.54
- TRULICITY (Drug) $91.21
- Ozempic (Drug) $89.06
- Rybelsus (Drug) $75.91
- UBRELVY (Drug) $60.92
- Horizant (Drug) $58.65
- JARDIANCE (Drug) $53.00
- FreeStyle Libre (Device) $52.79
- Vascepa (Drug) $50.28
- NURTEC ODT (Drug) $47.99
- SPIRIVA RESPIMAT (Drug) $47.92
- RYBELSUS (Drug) $43.17
- SHINGRIX (Biological) $33.57
- AREXVY (Drug) $32.22
- TRADJENTA (Drug) $26.77
- Aptima Trichomonas (Device) $19.43
- Xofluza (Drug) $16.77
- TOUJEO (Biological) $15.95
- BEVESPI AEROSPHERE (Drug) $14.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.